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Background: Previous studies have identified hypoalbuminemia as a risk factor for negative outcome in dogs with chronic
enteropathy (CE), but it has not been determined whether histopathology differs between CE dogs with and without hypoal-
buminemia.
Objective: To compare histopathologic findings in dogs with biopsy-diagnosed inflammatory CE with and without
hypoalbuminemia.
Animals: 83 dogs that had intestinal biopsy performed between January 2010–July 2015. Dogs had signs compatible with
CE of at least 3-weeks’ duration and no evidence of clinically relevant extra-gastrointestinal (GI) disease or potential non-GI
causes of hypoalbuminemia. Dogs had primary diagnosis of inflammatory enteritis based on histopathology.
Methods: Dogs were grouped into CE with normoalbuminemia (CEN; serum albumin concentration ≥3.0 g/dL, N = 46)
or chronic enteropathy with hypoalbuminemia (CEH; serum albumin concentration <3.0 g/dL, N = 37). A pathologist (SLP)
blinded to the groups reviewed biopsy samples and applied the World Small Animal Veterinary Association scoring system
to all samples.
Results: Intestinal biopsy samples from dogs in the CEH group were significantly more likely to display villous stunting,
epithelial injury, crypt distension, and lacteal dilatation, and were more likely to have intraepithelial lymphocytes and lamina
propria neutrophils than biopsy samples from dogs in the CEN group. Additionally, higher scores for each of the above
listed histopathologic criteria were associated with a lower serum albumin concentration.
Conclusions and Clinical Importance: Histopathologic features of chronic inflammatory enteropathy differ between dogs
that are hypo- versus normoalbuminemic. Additional work is needed to elucidate the clinical relevance of these differences.
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Chronic enteropathy (CE) is a term used to describevarious inflammatory conditions of the intestinal
tract.1 It is characterized by the presence of gastroin-
testinal (GI) signs such as weight loss, vomiting, diar-
rhea, and decreased appetite of at least several weeks’
duration, and is associated with histologic evidence of
inflammation in the small intestine.1–3 In dogs, the type
of CE often is determined by response to treatment and
can include antibiotic-responsive disease, food-respon-
sive disease, and idiopathic inflammatory bowel disease,
which may be steroid responsive.1 The prognosis is
reported to be highly variable1–5 and dependent on
response to treatment.6
When a GI disorder results in hypoalbuminemia as
a consequence of excessive loss of plasma proteins
through the intestinal mucosa, it is commonly referred
to as protein-losing enteropathy (PLE).7 Causes of
PLE are numerous, including diseases that result in
infiltration, inflammation, hemorrhage, or edema of
the GI tract,7 including intestinal lymphangiectasia, ali-
mentary lymphoma, hookworm infestation, infection
by Histoplasma capsulatum, and intestinal intussuscep-
tion.8 Chronic enteropathies can result in PLE,8 and
for the purposes of this study, we refer to this type of
PLE as chronic enteropathy with hypoalbuminemia
(CEH).
Although several previous studies have identified
hypoalbuminemia as a risk factor for negative outcome
in cases of CE, it is still unclear whether histopathology
differs between CE dogs with and without hypoalbu-
minemia.1,4,5 Historically, substantial interobserver vari-
ation in histopathologic evaluation of intestinal tissue
has compounded this problem,9 making it difficult to
compare changes among dogs with different categories
of intestinal disease. Recently, the GI Standardization
Group developed guidelines for the interpretation of
inflammatory change in the GI mucosa of the dog and
cat. These standards, known as the World Small Ani-
mal Veterinary Association (WSAVA) scoring system,
include classification and scoring of morphologic and
inflammatory changes in the canine intestinal mucosa.10
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The objective of our study was to compare
histopathologic findings (as determined by the WSAVA
scoring system) in dogs with biopsy-diagnosed CE with
and without hypoalbuminemia. Our hypothesis was that
dogs with CE and hypoalbuminemia would have differ-
ent histopathologic features than CE dogs without
hypoalbuminemia.
Materials and Methods
Electronic medical records at Colorado State University were
reviewed for dogs that had intestinal biopsy performed between
January 2010 and July 2015. Included dogs had clinical signs com-
patible with CE of at least 3-weeks’ duration, including weight
loss, diarrhea, vomiting, and decreased appetite, and intestinal
biopsy samples that indicated variable types and degrees of inflam-
matory infiltrate. Dogs were included if their primary diagnosis
was an inflammatory enteritis on their original histopathologic
evaluation. Additionally, all dogs had an appropriate history of
fecal testing or deworming, and most (67/83; 80%) had abdominal
ultrasonography performed before intestinal biopsy to screen for
intestinal or abdominal masses.
Dogs with clinically relevant concurrent extra GI disease, with
potential non-GI causes of hypoalbuminemia, with causes of GI
disease other than inflammatory enteritis (eg, intestinal lym-
phoma), or for which a complete medical record could not be
obtained, were excluded. Specifically, hypoalbuminemic dogs that
were not screened for proteinuria, had substantial proteinuria
(UPC >1.0), or had clinically abnormal serum bile acid concentra-
tions (preprandial >20 lmol/L; postprandial >40 lmol/L) were
excluded. Dogs were placed in either the CE with normoalbumine-
mia (serum albumin concentration ≥3.0 g/dL) group (chronic
enteropathy with normoalbuminemia, CEN) or the CE with
hypoalbuminemia (serum albumin concentration <3.0 g/dL) group
(CEH). Serum albumin concentration <3.0 g/dL was defined as
hypoalbuminemia based on the Colorado State University Diag-
nostic Laboratory’s normal reference interval for serum albumin
concentration in dogs (3.0–4.3 g/dL).
Recorded data included age, breed, sex, clinical signs, additional
clinicopathologic abnormalities, tissue types available, and biopsy
method. After cases were selected for study, histopathologic evalu-
ation of previously obtained intestinal tissue was performed by a
single pathologist blinded to clinical group (SLP). The pathologist
established that the biopsy samples were adequate for evaluation,
and then determined the presence of morphologic criteria (villous
stunting, epithelial injury, crypt distension, lacteal dilatation,
mucosal fibrosis) and inflammatory criteria (intraepithelial lym-
phocytes [IEL], lamina propria eosinophils, lamina propria lym-
phocytes or plasma cells, lamina propria neutrophils) and scored
the degree of change based on WSAVA guidelines. For the degree
of each change, the following scores were applied based on estab-
lished criteria: 0 = normal, 1 = mild, 2 = moderate, 3 = marked.
In cases where >1 tissue type was available, the tissue type with
the highest total WSAVA score was used in the analysis.
Statistical Analysis
The proportion of each variable present was compared between
the 2 groups (CEN versus CEH) using Fisher’s exact test. A
Spearman (rank-based) correlation also was performed to evaluate
for a correlation between score for each biopsy variable and serum
albumin concentration. A multiple logistic regression analysis then
was performed using those variables found to be significantly asso-
ciated with hypoalbuminemia based on Fisher’s exact test (crypt
distention, IEL, lacteal dilatation, neutrophils, villous epithelial
injury, and villous stunting). Specifically, hypoalbuminemia (yes or
no) was the response variable and the histopathologic variables
(presence/absence) were used as predictors. Backward elimination
then was used to decrease the number of predictors in the logistic
regression model. For Fisher’s exact test and Spearman’s correla-
tion analyses, a Bonferroni adjustment was used to account for
multiple testing.
Statistical significance for all analyses was defined as the proba-
bility of the null hypotheses (ie, no relationship or no difference)
being true at <5.0% (P < .05).
Results
Medical records of 270 dogs that underwent intestinal
biopsy at CSU (Colorado State University) from Jan-
uary 2010 to July 2015 were reviewed. Of the 270, 83
met the inclusion criteria. Ninety-six of the excluded
dogs had either evidence of clinically relevant concur-
rent extra-GI disease, or clinically relevant concurrent
extra-GI disease could not be excluded. Sixty-four of
the excluded dogs had a primary diagnosis other than
inflammatory enteritis as the cause of their chronic GI
signs (eg, chronic foreign body and neoplasia). In 27
excluded cases, no intestinal tissue or previously pre-
pared slide was available for evaluation.
Of the included dogs, 37/83 (45%) were hypoalbu-
minemic (CEH group; serum albumin concentration
<3.0 g/dL), and 46/83 (55%) were normoalbuminemic
(CEN group; serum albumin concentration ≥3.0 g/dL).
The median age of dogs in the CEH group was
3 years (range, 1–12 years). The median age of dogs in
CEN group was 2 years (range, 5 months–14 years). In
the CEH group, 3 dogs were intact males, 15 dogs were
castrated males, 1 dog was an intact female, and 18
dogs were spayed females. In the CEH group, 2 dogs
were intact males, 30 dogs were castrated males, 2 dogs
were intact females, and 12 dogs were spayed females.
There was no significant difference in age or sex status
between groups.
Breeds included mixed breed (15), Labrador Retriever
(9), German Shepherd Dog (4), Boxer (3), Cocker Spa-
niel (3), Pomeranian (3), West Highland White Terrier
(3), Australian Shepherd (2), Border Collie (2), English
Bulldog (2), French Bulldog (2), Golden Retriever (2),
Great Pyrenees (2), Newfoundland (2), Yorkshire Ter-
rier (2), and 1 each of the following: American Eskimo,
Airedale Terrier, Akita, Bernese Mountain Dog, Boston
Terrier, Chesapeake Bay Retriever, Doberman, Minia-
ture Dachshund, German Shorthaired Pointer, Giant
Schnauzer, Irish Setter, Maltese, Norwich Terrier, Lun-
dehund, Rottweiler, Soft Coated Wheaten Terrier,
Samoyed, Shar Pei, Shetland Sheepdog, Shiba Inu, Shih
Tzu, Siberian Husky, Saint Bernard, Standard Poodle,
Tibetan Terrier, and Weimaraner.
In the CEH group, biopsy samples were obtained by
endoscopy in 33/37 (89%) cases, with 24/33 (73%) hav-
ing only gastroduodenoscopy performed and 9/33 (27%)
having both gastroduodenoscopy and ileocolonoscopy
performed. Three dogs in the CEH group had intestinal
biopsy samples obtained celiotomy, and 1 dog by
laparoscopy. In the CEN group, biopsy samples were
obtained by endoscopy in 42/46 (91%) cases, with 22/42
(52%) having only gastroduodenoscopy performed and
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20/42 (48%) having both gastroduodenoscopy and ileo-
colonoscopy performed. Four dogs in CEN group had
intestinal biopsy samples obtained by celiotomy.
Method of biopsy procurement was not different
between groups. Median serum albumin concentration
in the CEH group was 1.9 g/dL (range, 0.8–2.8 g/dL).
Median serum albumin concentration in the CEN group
was 3.7 g/dL (range, 3.0–4.4 g/dL).
A Fisher’s exact test indicated that dogs in the CEH
group had a greater proportion of villous stunting,
epithelial injury, crypt distension, and lacteal dilatation
than did dogs in the CEN group. Additionally, dogs in
the CEH group had a greater proportion of IEL and
lamina propria neutrophils than did dogs in the CEN
group. Proportions of lamina propria eosinophils and
lamina propria lymphocytes or plasma cells were not
different between groups. The criterion of mucosal
fibrosis was not represented often enough to be suitable
for statistical analysis (Fig 1).
A rank-based Spearman’s correlation indicated that a
higher score for villous stunting, epithelial injury, crypt
distension, lacteal dilatation, IEL, or lamina propria
neutrophils was moderately associated with a lower
serum albumin concentration (Table 1).
After backward elimination (using alpha = 0.05),
multiple logistic regression analysis indicated that the
following variables remained significant: crypt disten-
sion (odds ratio [OR], 12.487; P < .001), intraepithelial
lymphocytes (OR, 10.060; P = .013), and lacteal dilata-
tion (OR, 5.037; P = .009). The OR represents the odds
of hypoalbuminemia comparing the presence versus the
absence of each histopathologic variable, with other
variables held constant.
Discussion
Lymphoplasmacytic or eosinophilic intestinal infil-
trates or both are considered the hallmark of idiopathic
CE. In our population of dogs with CE, the propor-
tions of lamina propria lymphoplasmacytic or eosino-
philic infiltrates were not different between the
hypoalbuminemic and normoalbuminemic groups.
Additionally, the proportions and severity of these infil-
trates were not correlated with serum albumin concen-
tration. This finding was not surprising, and it is in
agreement with previous studies, in which the histologic
scores of infiltrates of eosinophils, lymphocytes, or
plasma cells were not correlated with the patient’s
serum albumin concentration or outcome.1,5 Interest-
ingly, the cellular infiltrates that were different between
CEH and CEN dogs included IEL and lamina propria
neutrophils.
Intraepithelial lymphocytes are a component of the
first line of defense in the GI immune system and have
both pro- and anti-inflammatory roles.11,12 We found
that IEL were more likely to be present (P < .001) in
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Fig 1. The presence of histopathologic variables in dogs with CEH versus dogs with CEN. P values (Fischer’s exact test) and adjusted P
values (after Bonferroni correction) shown for significant and nonsignificant variables. *Retained significance in multivariate analysis; #Sta-
tistical tests unreliable because of low expression of this trait; LP, lamina propria; CEH, chronic enteropathy and hypoalbuminemia; CEN,
chronic enteropathy and normoalbuminemia.
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dogs with hypoalbuminemia versus normoalbuminemic
dogs with CE, but as a consequence of the retrospective
nature of our study, we were not able to classify these
cells further. Additional study is needed to determine
the role of these cells in dogs with CE.
Lamina propria neutrophils were more likely to be
present (P = .003) in dogs with hypoalbuminemia (17/
37; 46%) compared to dogs with normoalbuminemia
(7/46; 15%). Whether the neutrophils are representative
of an underlying etiology, are present because of adhe-
sion and possible translocation of microbial flora or
pathogens, or are simply part of the inflammatory
response is not well understood and deserves further
study.
Crypt distension also was found more often in dogs
with CEH versus dogs with CEN (P < .001). Previous
studies have reported on crypt lesions, sometimes
referred to as crypt abscesses, in dogs with PLE.13 In a
case series of 6 dogs with PLE,14 only 2/6 had inflamma-
tory infiltrates or lymphangiectasia histologically. Inter-
estingly, both dogs that had inflammatory infiltrates had
neutrophils noted in the lamina propria, and 5/6 dogs
had neutrophils present in distended crypts. In another
series of 58 dogs with CE, dogs with crypt abscesses were
found to have more severe intestinal protein loss and
shorter survival times than dogs with crypt distension or
no crypt lesions.15 The clinical relevance of crypt lesions
in dogs with CE also deserves further study.
Dilated lacteals were present in a high proportion of
dogs overall (44/83; 53%), but were significantly more
likely (P < .001) to be present in dogs with hypoalbu-
minemia (28/37; 76%) compared to dogs with normal
serum albumin concentration (16/46; 35%). A previous
retrospective analysis of full-thickness intestinal biopsy
samples in dogs with chronic GI disease showed that, in
38/64 dogs (59%), the major histopathologic abnormal-
ity was intestinal lymphangiectasia (dilated lacteals).
Lymphoplasmacytic enteritis (LPE) was identified in
only 5/64 dogs (8%).16 These findings are in contrast to
a study that evaluated histologic findings of endoscopic
biopsy samples in 368 dogs with chronic diarrhea, where
LPE was identified in approximately 25% of cases, and
lymphangiectasia was not common.17 The serum albu-
min concentration of dogs in these studies was not com-
pared. A more recent study evaluated the histologic
features of 136 dogs with chronic GI signs, 94 with
LPE, and 42 with GI disease not caused by inflamma-
tory bowel disease. All 94 dogs with LPE had lacteal
dilatation graded as moderate to severe by WSAVA
standards. Additionally, lacteal height, width, and
height/width ratio were inversely correlated with serum
albumin concentration in this group of dogs.18 The rea-
son for the discrepancies among the studies likely is
multifactorial, but could include the fact that intestinal
lymphangiectasia may be segmental or multifocal and
biopsies may miss these lesions if the affected area is not
sampled. Most of the biopsy samples in our study were
obtained endoscopically with the potential to miss
lesions deep within the submucosal and muscularis lay-
ers of the intestinal wall.19 Nonetheless, the high preva-
lence of intestinal lymphangiectasia in dogs with a
primary diagnosis of inflammatory enteritis may be
important. Although secondary lymphangiectasia is
thought to resolve with treatment targeting idiopathic
inflammatory bowel disease, it may be that dogs not
responding to this treatment would benefit from fat
restriction because of persistent intestinal lymphangiec-
tasia. Also, lymphatic dysfunction and lymphangiogene-
sis have long been suspected as a component of the
pathology of inflammatory bowel diseases in humans,
Table 1. Scores for histopathologic variables in dogs with chronic enteropathy and correlation with hypoalbuminemia
(Spearman rank-based).
Variable Group Med Min Max
Spearman’s
Correlation Score P Value Adjusted P Valuea
Crypt distension CEH 1 0 3 0.587 <.001 <.001
CEN 0 0 2
Intraepithelial lymphocytes CEH 0 0 3 0.347 .001 .01
CEN 0 0 1
Lacteal dilatation CEH 1 0 3 0.422 <.001 <.001
CEN 0 0 3
Eosinophils CEH 0 0 2 0.09 .42 1
CEN 0 0 3
Lymphocytes and plasma cells CEH 1 0 2 0.157 .16 1
CEN 0 0 2
Neutrophils CEH 0 0 3 0.308 .005 .04
CEN 0 0 2
Mucosal fibrosis CEH 0 0 1 NA NA NA
CEN 0 0 0
Villous epithelial injury CEH 0 0 3 0.372 <.001 .005
CEN 0 0 1
Villous stunting CEH 1 0 3 0.551 <.001 <.001
CEN 0.5 0 2
CEH, chronic enteropathy with hypoalbuminemia; CEN, chronic enteropathy with normoalbuminemia; LP, lamina propria; NA, not
applicable: statistical tests unreliable due to low expression of this trait.
aAfter Bonferroni correction.
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and therapeutic interventions to stimulate lymphatic
function have shown some promise in recent experimen-
tal murine models of inflammatory bowel disease.20–23
In a previous study of dogs with diet-responsive
enteropathy, WSAVA histopathologic scoring identified
more villous stunting in the enteropathy dogs versus
controls.24 Ultrastructural lesions of the mitochondria
and brush border also were evaluated and in those dogs
clinically responsive to food, and the microvillus height
and additional ultrastructural lesions improved. The
authors postulated that the recovery of enterocyte
health after clinical response to diet suggests that archi-
tectural changes may be at least as important as more
standard measures of pathology in the intestine, namely
inflammatory infiltrates. It was suggested that this
might explain why previous studies have failed to iden-
tify improvement in the inflammatory infiltrates of dogs
with CE, despite clinical improvement.24 Our study is in
agreement that the morphologic lesions appear to be
important in dogs with CE. Additionally, because these
lesions were more common in hypoalbuminemic dogs,
we suspect they may indicate a more severe form of
CE. Whether the presence or relative severity of these
lesions indicates a possible alternative etiology or the
need for alternative treatment approaches is unknown.
A prospective study in which clinical data and response
to treatment can be monitored based on the histologic
criteria is warranted.
Our study had several limitations. The median age of
dogs in our CEH and CEN groups was younger (CEH,
3 years; CEN, 2 years) when compared to other studies
of dogs with CE.1,25–28 Therefore, our population of
dogs with CE may not reflect those seen at other insti-
tutions. Additionally, the retrospective design of our
study did not allow us to determine the dogs that had
received proper food or antibiotic trials before intestinal
biopsy so that we could better classify them. Therefore,
we applied the term CE to these cases, rather than idio-
pathic inflammatory bowel disease. However, at our
institution, it is common for food and antibiotic trials
to be completed before the recommendation of biopsy,
provided the patient is stable. Response to treatment
and prognosis as it relates to the above histopathologic
features could not be determined because of incomplete
follow-up of many of the cases. Most biopsy samples
were obtained endoscopically, which is the standard of
practice at our institution but does have limitations, as
described above.19 Also, ileal biopsy samples (via ileo-
colonoscopy, celiotomy, or laparoscopy) were obtained
in just 35% of dogs with CEH and 57% of dogs with
CEN. The method of biopsy sample procurement was
not different between groups, but a larger proportion of
the CEN dogs had ileal biopsy samples obtained, which
may have affected the results. Pathology can differ
among sections of small intestine,26,29 and ideally, ileal
biopsy samples would have been available for evalua-
tion in all dogs. Finally, despite the use of the WSAVA
guidelines for histopathologic scoring of endoscopic
intestinal biopsy samples, substantial interobserver vari-
ability occurs, controversy still exists, and scoring is still
considered relatively subjective.30
In conclusion, many histopathologic features of
chronic inflammatory enteropathy differ between dogs
that are hypo- versus normoalbuminemic. The classic
features of CE, lymphoplasmacytic cellular infiltrate
and eosinophilic infiltrates, were not different between
groups, whereas other inflammatory infiltrates and
many of the morphologic features were different. These
morphologic lesions may simply indicate a more severe
disease process occurring in the intestine. Additional
work is needed to elucidate the clinical relevance of
these differences and to determine whether the presence
or relative severity of these lesions indicates a possible
alternative etiology or the need for alternative or supple-
mental treatment strategy in some cases of CE in dogs.
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